Table 1.
Transcriptome-based molecular subtypes of human pancreatic cancer and stroma and their effects on survival
| Classification | Molecular subtype | Effect on survival |
|---|---|---|
| Collisson et al. [3] | Quasimesenchymal | ↓1 |
| Exocrine-like | ||
| Classical | ||
| Bailey et al. [4▪▪] | Squamous | ↓1 |
| ADEX2 | ||
| Pancreatic progenitor | ↓3 | |
| Immunogenic | ↓4 | |
| Moffitt et al. [5] | Basal-like5 | ↓1 |
| Classical6 | ||
| ‘Normal’ stroma | ||
| ‘Activated’ stroma | ↓7 |
This group has the worst survival in the respective classification.
Aberrantly differentiated endocrine and exocrine.
Within the progenitor group, patients with a higher expression of genes in this gene program have a worse prognosis.
Within the immunogenic group, high macrophage and T-cell coinhibition signatures are associated with a worse prognosis.
The basal group only partially overlaps with the quasimesenchymal group.
The classical group only partially overlaps with the Collisson classical group.
‘Activated’ stroma was associated with a worse prognosis when compared with ‘normal’ stroma. Stromal types are not tumor subtype specific.
The different classification schemes by the authors are shown. The matching colors correspond to overlapping groups under the different classification schemes. The Moffitt tumor subtypes only have partial overlap with the other corresponding groups.